Clinical Trials in Cleveland

Showing 1201-1220 of 19,775 trials

A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis

NCT06773195

The researchers are doing this study to find out whether the combination of ruxolitinib and ulixertinib is a safe and effective treatment for people with myelofibrosis. The researchers will test different doses of ulixertinib to find the highest dose that causes few or mild side effects in participants when given in combination with ruxolitinib.

Myelofibrosis

Memorial Sloan Kettering Cancer Center37 participantsStarted Jan 2025

Boston, Massachusetts, United States • Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States +6 more locations

RECRUITINGNA67 miles

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

NCT05108298

The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.

Breast Cancer, NOSCNS Primary Tumor, NOSCervical Cancer, NOS+9 more

Eastern Cooperative Oncology Group400 participantsStarted Nov 2021

Fairbanks, Alaska, United States • Kingman, Arizona, United States • Phoenix, Arizona, United States +344 more locations

A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Find Trials by Condition in Cleveland

A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus

Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care

Real World Evidence Study in Subjects With Wilson's Disease

Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

Open-Label Study of 18F-mFBG for Imaging Neuroblastoma

Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis

Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age

EVR and EPO for Liver Transplant Tolerance

RemI for Post-Bariatric Surgery Weight Regain

Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia

A First-in-Human Study of BGB-C354 Alone and in Combination With Tislelizumab in Participants With Advanced Solid Tumors

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome